Skip to main content
search
All Posts By

admin

Membership NewsMembership News Archive

UK Health Security Agency, strategy and collaboration

BIVDA now has over 200 members from the IVD industry and can confidently liaise with stakeholders as the voice of the industry. We are in a unique position in being the representative Association for around 95% of IVD companies operating in the UK. The structure of our membership spans across spin outs and start-ups, through to multi-nationals across all disciplines,…
admin
February 11, 2022
HighlightsHighlights Archive

Media Monitoring: 4/2 – 11/2

US research director appointed first chief executive of Advanced Research and Invention Agency Dr Peter Highnam to head up the Advanced Research and Invention Agency (ARIA) as its first CEO Backed by £800 million, it will empower exceptional scientists to focus on high-risk projects at the frontier of discovery and innovation that could transform people’s lives for the better, maintaining…
admin
February 11, 2022
HighlightsHighlights Archive

£10 million in funding announced for innovative cancer diagnostic approaches

Nearly £10 million in funding is to be provided to eight new projects in cancer diagnostic innovation. These projects cover blood tests, artificial intelligence, mobile phone technologies, diagnostic software and are set to transform cancer diagnoses into the future. All of these projects are being fast-tracked into the NHS in order to maximise the efficient diagnosis of cancers in UK…
admin
February 11, 2022
Digital Working PartyDigital Working Party Archive

BIVDA Digital Working Party – Tuesday 15 February 2022 – 09.30am – 11.00am

The Digital Working party is scheduled to be held on Tuesday 15 February via Teams. Agenda 09:30 Welcome, introductions and apologies  - Phil Groom, Chair 09.35 Competition Law -  Doris-Ann Williams, BIVDA 09.40 Minutes of last meeting and matters arising - Phil Groom, Chair 09.45 An industry overview of data, digital and future innovation - Nathan Sharpe - Charlton Morris…
admin
February 9, 2022
Membership NewsMembership News Archive

Covid-19 Desktop Validation – BIVDA Update

There have been a number of approvals which are set to be released imminently, so members should review the approved list which can be found at CTDA - approved-products Over the Christmas period, most suppliers have provided the outstanding requested information and those are still in the evaluation stages. There are approximately a dozen suppliers that have been rejected, but…
admin
February 4, 2022
Member RequestsMember Requests Archive

Feedback required on the use of GBL in products

GBL is metabolised in the body to Gamma-hydroxybutyrate (GHB), which is commonly used as a ‘date-rape’ drug. This legislation is due to come into force in June 2022. This classification change will mean that any organisations using GBL within their products will require a licence from the Home Office in order for it to be accessed and used. BIVDA is…
admin
February 4, 2022
Close Menu